NDAORALSYRUPPriority Review
Approved
Sep 1993
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
FLUMADINE (rimantadine hydrochloride) by Forest Devices is mechanism of action the mechanism of action of rimantadine is not fully understood. First approved in 1993.
Drug data last refreshed 13h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FLUMADINE (rimantadine hydrochloride) is an oral antiviral syrup approved in 1993 for the treatment of influenza A virus infections. It works by inhibiting viral uncoating early in the replicative cycle, targeting the M2 protein encoded by the influenza A virion. Rimantadine is a small-molecule adamantane derivative used primarily for prophylaxis and treatment of influenza A.
LOE Approaching
As a 30-year-old product approaching loss of exclusivity with moderate competitive pressure (30), the brand team is likely focused on transition planning and cost management rather than growth initiatives.
Mechanism of Action
Mechanism of Action The mechanism of action of rimantadine is not fully understood. Rimantadine appears to exert its inhibitory effect early in the viral replicative cycle, possibly inhibiting the uncoating of the virus. Genetic studies suggest that a virus protein specified by the virion M 2 gene…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FLUMADINE offers limited growth trajectory and is best suited for professionals focused on operational excellence, cost management, and transition planning rather than innovation or career acceleration. This product is ideal for early-to-mid career professionals seeking stable, defensive marketing roles or those nearing product discontinuation.
Brand Manager (Maintenance)
Worked on FLUMADINE at Forest Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.